PDCD1 and neoplasm: Furthermore, immune-related events within the tumor microenvironment (TME), such as the diversity of tumor-infiltrating lymphocytes (TILs) and the expression of programmed cell death protein-1 (PD-1) and ligand-1 (PD-L1), can vary across the different metastasized organs within a patient.